Active Ingredient: BIVALIRUDIN
Proprietary Name: BIVALIRUDIN
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 250MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A213078
Product Number: 001
Approval Date: May 28, 2021
Applicant Holder Full Name: SLATE RUN PHARMACEUTICALS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information